Stock Research: Ryman Healthcare

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Ryman Healthcare

NZC:RYM NZRYME0001S4
13
  • Value
    43
  • Growth
    34
  • Safety
    Safety
    8
  • Combined
    56
  • Sentiment
    15
  • 360° View
    360° View
    13
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for older people. It provides retirement-living options like apartments and townhouses, assisted living, and aged-care services including dementia care. The company operates across New Zealand and Australia. In the last fiscal year, the company had a market cap of $1558 millions, NULL in profits, $432 millions in revenue, and 7800 employees.

more
Index
NZSX 50
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 19-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
43 41 49 55
Growth
34 19 31 21
Safety
Safety
8 8 8 8
Sentiment
15 23 18 34
360° View
360° View
13 13 13 15
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
27 64 55 3
Opinions Change
50 68 6 50
Pro Holdings
n/a 11 23 86
Market Pulse
7 4 11 36
Sentiment
15 23 18 34
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
43 41 49 55
Growth
34 19 31 21
Safety Safety
8 8 8 8
Combined
56 56 56 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
38 33 27 17
Price vs. Earnings (P/E)
48 75 91 53
Price vs. Book (P/B)
92 95 91 59
Dividend Yield
1 1 1 82
Value
43 41 49 55
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
51 60 46 71
Profit Growth
93 8 46 27
Capital Growth
21 13 24 25
Stock Returns
6 37 47 31
Growth
34 19 31 21
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
45 21 26 12
Refinancing
24 24 24 24
Liquidity
22 1 6 10
Safety Safety
8 8 8 8

Similar Stocks

Discover high‑ranked alternatives to Ryman Healthcare and broaden your portfolio horizons.

Mitsubishi HC Capital

TYO:8593
Country: Japan
Industry: Specialized Finance
Size: X-Large
Full Stock Analysis

BML

TYO:4694
Country: Japan
Industry: Health Care Services
Size: Medium
Full Stock Analysis

Ship Healthcare Holdings

TYO:3360
Country: Japan
Industry: Health Care Distributors
Size: Large
Full Stock Analysis

Alfresa Holdings

TYO:2784
Country: Japan
Industry: Health Care Distributors
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This is a highly risky stock investment proposition as all consolidated ranks are below-average. There are no compelling arguments to support this stock based on current information. It is not recommended for any investor profile. However, performance does change, so it could we worth keepin on a watchlist.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: